dc.contributor.author | Vilanova Urdaniz, Iosune | |
dc.contributor.author | Hernández Hernández, José Luis | |
dc.contributor.author | Mata Arnaiz, María Cristina | |
dc.contributor.author | Durán, C | |
dc.contributor.author | García Unzueta, María Teresa | |
dc.contributor.author | Portilla González, Virginia | |
dc.contributor.author | Fuentevilla Rodríguez, Patricia | |
dc.contributor.author | Corrales Martínez, Alfonso | |
dc.contributor.author | González Vela, María del Carmen | |
dc.contributor.author | González-Gay Mantecón, Miguel Ángel | |
dc.contributor.author | Blanco Alonso, Ricardo | |
dc.contributor.author | González López, Marcos Antonio | |
dc.contributor.other | Universidad de Cantabria | es_ES |
dc.date.accessioned | 2019-04-11T09:05:50Z | |
dc.date.available | 2019-06-01T02:45:13Z | |
dc.date.issued | 2018-05 | |
dc.identifier.issn | 0926-9959 | |
dc.identifier.issn | 1468-3083 | |
dc.identifier.uri | http://hdl.handle.net/10902/16148 | |
dc.description.abstract | Background: The association between chronic inflammatory diseases, such as rheumatoid arthritis and psoriasis, and insulin resistance (IR) has been well established. Hidradenitis suppurativa (HS) is a chronic inflammatory cutaneous disease that affects the apocrine glandbearing areas of the body.
Objective: We aimed to determine the prevalence of IR in patients with HS.
Methods: This cross-sectional, case-control study enrolled 137 subjects, 76 patients with HS and 61 age- and gender-matched controls. Demographic data, clinical examination of HS patients, anthropometric measures, cardiovascular risk factors and laboratory studies were recorded. The homeostasis model assessment of IR (HOMA-IR) was calculated in all participants by measuring fasting plasma glucose and insulin levels.
Results: The median (IQR) HOMA-IR value in HS patients was significantly higher [2.0 (1.0-3.6)] than in controls [1.5(0.9-2.3)] (p=0.01). The prevalence of IR was significantly higher in cases (43.4%) compared with controls (16.4%) (p=0.001). In the linear regression multivariable analysis after adjusting for age, sex and body mass index (BMI), HS remained as a significant factor for a higher HOMA-IR [2.51(0.18) vs 1.92(0.21); p=0.04]. The HOMA-IR value and the prevalence of IR did not differ significantly among HS patients grouped by severity of the disease.
Conclusion: Our results show an increased frequency of IR in HS. Thus, we suggest HS patients to be evaluated for IR and managed accordingly. | es_ES |
dc.format.extent | 19 p. | es_ES |
dc.language.iso | eng | es_ES |
dc.publisher | Wiley | es_ES |
dc.rights | © European Academy of Dermatology and Venereology. Published by Wiley. This is the peer reviewed version of the following article: Insulin resistance in hidradenitis suppurativa: a case-control study, which has been published in final form at https://doi.org/10.1111/jdv.14894. This article may be used for non-commercial purposes in accordance with Wiley Terms and Conditions for Self-Archiving. | es_ES |
dc.source | J Eur Acad Dermatol Venereol. 2018 May;32(5):820-824 | es_ES |
dc.title | Insulin resistance in hidradenitis suppurativa: a case-control study | es_ES |
dc.type | info:eu-repo/semantics/article | es_ES |
dc.rights.accessRights | openAccess | es_ES |
dc.identifier.DOI | 10.1111/jdv.14894 | |
dc.type.version | acceptedVersion | es_ES |